JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL1 kinase directly enhances JAK2/STAT activation to promote cell growth/survival in CML models [84, 85], and it requires an intact JAK2/STAT5 pathway to enable oncogenic transformation [83].